Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
new york blog main
3
×
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
3
×
startups
3
×
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
crispr therapeutics
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
national
president trump
raleigh-durham blog main
raleigh-durham top stories
roche
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
acetylon pharmaceuticals
adverum biotechnologies
albert bourla
alzheimer's disease
ambys medicines
What
today
3
×
biotech
drug
future
roundup
acquisitions
ahead
aiming
albert
ambien
ambys
american
annual
asco
attendees
attention
big
biggest
bio
bourla
camp’s
cancer
cash
ceo
chicago
city
clinical
combinations
community’s
company
control
crispr
days
deadly
deal
debuted
diseases
expanding
focus
formed
Language
unknown
Current search:
today
×
startups
×
" san francisco top stories "
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More